In our colorectal cancer quiz, you’ll get to test your knowledge on mismatch-repair deficiency in patients with colorectal cancer and the results of the KEYNOTE-177 trial.
How common is colorectal cancer (CRC)?
a. CRC is the third most commonly diagnosed cancer in men and women.
b. CRC is the fifth most commonly diagnosed cancer in men and women.
c. CRC is the second most commonly diagnosed cancer in men and women.
d. CRC is the most commonly diagnosed cancer in men and women.
FDA Issues CRL for Zolbetuximab in Advanced CLDN18.2+ Gastric Cancer
January 9th 2024The FDA cannot approve the application for zolbetuximab in advanced or metastatic gastric or gastroesophageal junction adenocarcinoma due to unresolved issues following a pre-license inspection of a third-party manufacturing site.
Quiz: Detecting Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma
August 10th 2020In our liver cancer quiz, you’ll get a chance to test your knowledge on recurrence following resection in patients with intrahepatic cholangiocarcinoma and the new tools being developed to aid in treating this patient population.